Market Closed -
Other stock markets
|
Pre-market 12:47:27 | |||
130.2 USD | -1.24% |
|
129.7 | -0.36% |
06-11 | Merck looks for next-generation opportunities in cardiometabolic drugs | RE |
06-11 | Merck & Co., Inc. to Seek Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.43% | 330B | |
+48.79% | 781B | |
+41.51% | 639B | |
+7.18% | 293B | |
+17.30% | 248B | |
-0.12% | 221B | |
+11.38% | 217B | |
+4.53% | 162B | |
-3.92% | 157B | |
-1.25% | 121B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Merck Says Keytruda Meets Primary Endpoint in Late-Stage Gastric Cancer Trial